HLN
HaleonBNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
HLN vs peer average
61/100
HLN vs. peer average (B vs. C)
Grade spread
A 2 · B 3 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Large-cap biopharma comparator supplied in the packet, but its therapeutics model is not directly comparable with Haleon’s branded consumer-health portfolio; valuation comparison is low signal.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
HLN
Haleon
AMGN
Amgen
Grade
B
D
Momentum
32
70
Value
66
63
Sentiment
71
45
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs AMGN
HLN / AMGN
Grade Position
In line
HLN vs. peer average (B vs. C)
61/100
Momentum
32
AMGNValue
66
HLNSentiment
71
HLNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs HLN
AMGN is the first peer returned for this comparison set.

